In addition, we demonstrated that both JQ1 and dBET1 effectively reduced IGF2BP3 expression in MCC cells, implicating the involvement of BRD family proteins in the regulation of IGF2BP3 levels. This evidence concerns the gene IGF2BP3 and Merkel cell skin cancer.